Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ignacio García-Ribas, MD
Oncomatryx Biopharm, S.L.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
9 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Universitari Vall D'Hebron
Barcelona, Barcelona, Spain
Not, yet, recruiting - Ico L'Hospitalet
L'Hospitalet de Llobregat, Barcelona, Spain
Recruiting - Hospital Clínico Universitario de Santiago
Santiago de Compostela, Galicia, Spain
Not, yet, recruiting - Hospital Universitario de Donostia
San Sebastián, Guipúzcoa, Spain
Recruiting - Hospital 12 Octubre
Madrid, Madrid, Spain
Recruiting - Hospital Md Anderson
Madrid, Madrid, Spain
Recruiting - Clínica Universitaria de Navarra
Pamplona, Navarre, Spain
Recruiting - Onkologikoa
San Sebastián, Spain
Recruiting
- Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 20 Oct 2022
- Primary completion
- 31 Dec 2027
- Completion
- 31 Dec 2027
- Last update posted
- 25 Nov 2025
- Registered enrollment
- 150
- Registry id
- NCT05547321
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.